Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03229211
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
CLG | 2-AMINO-6-[2-(2-AMINOOXY-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.71 | |
SAC | N-ACETYL-SERINE | A,B,C,D,F,G, I,J,L,M,N,O, P,Q,S,T,V,W,Z | 2EIL | 0.85 | |
SAC | N-ACETYL-SERINE | A,B,C,D,F,G, I,J,L,M,N,O, P,Q,S,T,V,W,Z | 2DYR | 0.85 | |
SAC | N-ACETYL-SERINE | A,B,C,D,F,G, I,J,L,M,N,O, P,S,T,V,W,Z | 2EIM | 0.85 | |
SAC | N-ACETYL-SERINE | A | 1R4U | 0.85 | |
SAC | N-ACETYL-SERINE | A,B,C,D | 1WS3 | 0.85 | |
SAC | N-ACETYL-SERINE | A,B,C,D,E,F, G,H | 1XY3 | 0.85 | |
SAC | N-ACETYL-SERINE | A,B | 1EVU | 0.85 | |
SAC | N-ACETYL-SERINE | A,B,C,D,E,F, G,H | 1R56 | 0.85 | |
SAC | N-ACETYL-SERINE | A,B,C,D,F,G, I,J,L,M,N,O, P,S,T,V,W,Z | 2DYS | 0.85 | |
SAC | N-ACETYL-SERINE | A | 1WRR | 0.85 | |
SAC | N-ACETYL-SERINE | A,B,C,D,E,F, G,I,J,L,M,N, O,P,Q,S,T,V, W,Z | 1V54 | 0.85 | |
SAC | N-ACETYL-SERINE | A,B | 3CVQ | 0.85 | |
SAC | N-ACETYL-SERINE | A | 1B0B | 0.85 | |
SAC | N-ACETYL-SERINE | A | 1XT4 | 0.85 | |
SAC | N-ACETYL-SERINE | A,B,C,F,G,I, J,L,M,N,O,P, S,T,V,W,Z | 2EIJ | 0.85 | |
SAC | N-ACETYL-SERINE | A | 2FXL | 0.85 | |
SAC | N-ACETYL-SERINE | A | 1R4S | 0.85 | |
SAC | N-ACETYL-SERINE | A,B,C,D | 1WS2 | 0.85 | |
SAC | N-ACETYL-SERINE | A,B,C,D | 2AUC | 0.85 | |
SAC | N-ACETYL-SERINE | A,B,C,D,F,G, I,J,L,M,N,O, P,S,T,V,W,Y,Z | 2EIN | 0.85 | |
SAC | N-ACETYL-SERINE | A | 1R51 | 0.85 | |
SAC | N-ACETYL-SERINE | A,B,C,E,F,G, I,J,M,N,O,P, Q,S,T,V,W,Z | 1V55 | 0.85 | |
SAC | N-ACETYL-SERINE | A,B,C,D | 1XXJ | 0.85 | |
SAC | N-ACETYL-SERINE | T | 2QAC | 0.85 | |
SAC | N-ACETYL-SERINE | A,B,C,E,F,G, I,J,L,M,N,O, P,Q,S,T,V,W, Y,Z | 2EIK | 0.85 | |
5FP | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID | A,B | 1XE6 | 0.74 | |
AYA | N-ACETYLALANINE | A | 1D0W | 0.74 | |
AYA | N-ACETYLALANINE | A | 1AH4 | 0.74 | |
AYA | N-ACETYLALANINE | A,B | 1VBP | 0.74 | |
AYA | N-ACETYLALANINE | A,B,C,D,E,F, G,H | 1J4T | 0.74 | |
AYA | N-ACETYLALANINE | A,B,C,D | 1OUW | 0.74 | |
AYA | N-ACETYLALANINE | A | 1AH3 | 0.74 | |
AYA | N-ACETYLALANINE | A | 1EKO | 0.74 | |
AYA | N-ACETYLALANINE | B,D,F,H | 2V4I | 0.74 | |
AYA | N-ACETYLALANINE | A,B,C,D,E,F, G,H | 1VBO | 0.74 | |
AYA | N-ACETYLALANINE | A,B,C,D | 1J4U | 0.74 | |
IVS | 3-HYDROXY-6-METHYL-4-(3-METHYL- 2-(3-METHYL-2-(3-METHYL-BUTYRYLAMINO)- BUTYRYLAMINO)-BUTYRYLAMINO)-HEPTANOIC ACID ETHYL ESTER | A,B | 1ME6 | 0.71 | |
NLG | N-ACETYL-L-GLUTAMATE | A | 1OH9 | 0.7 | |
NLG | N-ACETYL-L-GLUTAMATE | A | 1OHA | 0.7 | |
NLG | N-ACETYL-L-GLUTAMATE | A,B,C,D,E,F, G,H,I,J,K,L | 2BUF | 0.7 | |
NLG | N-ACETYL-L-GLUTAMATE | A,B,C,D | 2RD5 | 0.7 | |
NLG | N-ACETYL-L-GLUTAMATE | A,B | 2JJ4 | 0.7 | |
NLG | N-ACETYL-L-GLUTAMATE | A,B,C,D,E,F, G,H,J,K | 2V5H | 0.7 | |
NLG | N-ACETYL-L-GLUTAMATE | A | 1GSJ | 0.7 | |
NLG | N-ACETYL-L-GLUTAMATE | A | 3B8G | 0.7 | |
NLG | N-ACETYL-L-GLUTAMATE | A | 1GS5 | 0.7 | |
NLG | N-ACETYL-L-GLUTAMATE | A,B,C | 2BTY | 0.7 | |
DTH | D-THREONINE | A | 1KRO | 0.71 | |
DTH | D-THREONINE | A,B,C,D | 3BOG | 0.71 | |
DTH | D-THREONINE | A,B | 173D | 0.71 | |
DTH | D-THREONINE | A | 209D | 0.71 | |
DTH | D-THREONINE | A | 316D | 0.71 | |
DTH | D-THREONINE | A,B | 2Q33 | 0.71 | |
DTH | D-THREONINE | A | 2JUE | 0.71 | |
DTH | D-THREONINE | A | 2D55 | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 3EMY | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 2H6T | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1LS5 | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1SME | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,C | 1W6I | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1XDH | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 2QZX | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 1IZE | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1M43 | 0.71 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G65 | 0.7 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G6A | 0.7 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G68 | 0.7 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | C,D,E,X,Y,Z | 2FG7 | 0.7 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G6C | 0.7 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | C,D,E,X,Y,Z | 2FG6 | 0.7 | |
75V | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE | A | 2DCA | 0.71 | |
LNT | N-[(2S)-2-amino-1,1-dihydroxy-4- methylpentyl]-L-threonine | A,B,C | 3B80 | 0.78 | |
LNT | N-[(2S)-2-amino-1,1-dihydroxy-4- methylpentyl]-L-threonine | A,B,C | 3B7V | 0.78 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,B | 1OEX | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A | 2OWX | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,I | 1GVW | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,I | 1GVX | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A | 2OWW | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,B | 1GKT | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A | 2OWC | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,I | 1GVV | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,I | 1GVT | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,B | 2VS2 | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A | 1OEW | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,I | 1GVU | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,B | 2JJJ | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,B | 2JJI | 0.7 | |
N10 | O-[(HEXYLAMINO)CARBONYL]-L-SERINE | A,B,C,D,E,F, G,H | 2Q0S | 0.71 | |
DSE | N-METHYL-D-SERINE | C | 1CWH | 0.75 | |
PAU | PANTOTHENOIC ACID | A,B | 2F9W | 0.71 | |
PAU | PANTOTHENOIC ACID | A,B,C,D,E,F | 3BF1 | 0.71 | |
PAU | PANTOTHENOIC ACID | A,B,C,D | 1SQ5 | 0.71 | |
PAU | PANTOTHENOIC ACID | A,B,C,D,E,F | 3BEX | 0.71 | |
REY | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANINE | A | 1IKI | 0.7 | |
AOR | N~2~-ACETYL-L-ORNITHINE | A | 1ZQ6 | 0.72 | |
PT3 | N-PROPYL-TARTRAMIC ACID | A,B,C,D | 2HPA | 0.77 | |
074 | [PROPYLAMINO-3-HYDROXY-BUTAN-1,4- DIONYL]-ISOLEUCYL-PROLINE | A | 1QDQ | 0.71 | |
HY3 | 3-HYDROXYPROLINE | A,B,G | 2G66 | 0.73 | |
AN0 | N-ACETYL-L-NORVALINE | C,D,E,X,Y,Z | 2G7M | 0.74 | |
AN0 | N-ACETYL-L-NORVALINE | A | 1ZQ8 | 0.74 | |
5FE | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID METHYL ESTER | A,B | 1XE5 | 0.73 | |
NLQ | N~2~-ACETYL-L-GLUTAMINE | A,B,C,D | 2GGH | 0.7 | |
NLQ | N~2~-ACETYL-L-GLUTAMINE | A,B,C,D | 1XPY | 0.7 | |
C99 | {(2R)-2-[(1S,2R)-1-AMINO-2-HYDROXYPROPYL]- 2-HYDROXY-4,5-DIOXOIMIDAZOLIDIN- 1-YL}ACETIC ACID | A | 2HCG | 0.78 | |
U17 | METHYL N-[(2S,3R)-3-AMINO-2-HYDROXYHEPTANOYL]- L-SERYL-L-LEUCINATE | A | 2GGB | 0.71 | |
042 | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-THREONYL-L-ISOLEUCINE | A | 2DC7 | 0.7 | |
DLS | DI-ACETYL-LYSINE | A,B,C,D,E,F | 1FVM | 0.7 | |
CLH | 2-AMINO-6-[2-(2-OXO-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.71 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHA | 0.75 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHB | 0.75 | |
THC | N-METHYLCARBONYLTHREONINE | A,B,C | 1A7C | 0.9 | |
THC | N-METHYLCARBONYLTHREONINE | B | 2HR0 | 0.9 | |
THC | N-METHYLCARBONYLTHREONINE | L,P | 2MPA | 0.9 | |
THC | N-METHYLCARBONYLTHREONINE | L,P | 1MPA | 0.9 | |
SUJ | (2R,3R)-2-[(3S,6R)-3-AMINO-6-HYDROXY- 2-OXOPIPERIDINYL]-3-HYDROXYBUTANOIC ACID | C,D | 1OKX | 0.77 | |
PCV | 5-AMINO-3-HYDROXY-2-(2-OXO-AZETIDIN- 1-YL)-PENTANOIC ACID | A | 1DRT | 0.77 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PPP | 0.78 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PE6 | 0.78 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1ITO | 0.78 | |
ALO | ALLO-THREONINE | I,P | 1HDT | 0.71 | |
ALO | ALLO-THREONINE | A | 2JUU | 0.71 | |
ALO | ALLO-THREONINE | A | 2VMX | 0.71 |